AJU IB Investment Company’s Kymera Therapeutics KYMR Stock Holding History

AJU IB Investment Company’s Portfolio KYMR Stock Details KYMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-19,648	Closed	-$1.64M	–	2
2026 Q1	$1.64M	Hold	19,648	–	–	5.36%	2
2025 Q4	$1.53M	Sell	19,648 -437,411	-96%	-$29.5M	6.71%	3
2025 Q3	$25.9M	Hold	457,059	–	–	22.47%	2
2025 Q2	$19.9M	Hold	457,059	–	–	21.71%	2
2025 Q1	$12.5M	Hold	457,059	–	–	14.88%	2
2024 Q4	$18.4M	Buy	+457,059	New	+$20.6M	17.89%	2
2022 Q3	$9.95M	Hold	457,059	–	–	17.03%	3
2022 Q2	$9M	Hold	457,059	–	–	17.42%	2
2022 Q1	$19.3M	Hold	457,059	–	–	29.87%	2
2021 Q4	$29M	Sell	457,059 -182,000	-28%	-$10.6M	40.43%	1
2021 Q3	$37.5M	Hold	639,059	–	–	24.22%	2
2021 Q2	$31M	Hold	639,059	–	–	17.87%	3
2021 Q1	$24.8M	Sell	639,059 -65,000	-9%	-$3.91M	9.37%	4
2020 Q4	$43.7M	Buy	+704,059	New	+$34.3M	16.52%	4

Other funds holding KYMR

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

AJU IB Investment Company's KYMR Position: Q2 2026 in Review

AJU IB Investment Company sold out of Kymera Therapeutics (KYMR) in Q2 2026, closing a stake of 19,648 shares — an estimated $1.64M sold.

AJU IB Investment Company first reported a position in KYMR in Q4 2020 and held it in 14 quarters. The position peaked at $43.7M in Q4 2020. 81 funds tracked by Wall St. Rank hold KYMR as of Q2 2026.

AJU IB Investment Company reported no remaining Kymera Therapeutics position as of Q2 2026 after selling out during the quarter.
AJU IB Investment Company sold 19,648 Kymera Therapeutics shares in Q2 2026, an estimated $1.64M.
AJU IB Investment Company first reported a position in Kymera Therapeutics in Q4 2020 and held it in 14 quarters.
AJU IB Investment Company's Kymera Therapeutics position peaked at $43.7M in Q4 2020.
81 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q2 2026.

Based on AJU IB Investment Company's 13F filing for Q2 2026.